the favorable response to mitoxantrone in patients with prior anthracycline antibiotic therapy suggests that the drug is not fully cross-resistant with anthracycline antibiotics , and that this drug is of value in combination with other drugs as a salvage therapy for patients with refractory or relapsed malignant lymphomas .
C0026259
mitoxantrone
C0024299
malignant lymphomas